Emcure Pharmaceuticals Limited (NSE:EMCURE)
1,805.00
-4.50 (-0.25%)
Jul 10, 2026, 3:29 PM IST
Emcure Pharmaceuticals Market Cap
Emcure Pharmaceuticals has a market cap or net worth of 343.99 billion as of July 10, 2026. Its market cap has increased by 36.94% in one year.
Market Cap
343.99B
Enterprise Value
357.99B
Revenue
92.04B
Ranking
n/a
PE Ratio
37.20
Stock Price
1,805.00
Market Cap Chart
Since July 10, 2024, Emcure Pharmaceuticals's market cap has increased from 256.95B to 343.99B, an increase of 33.87%. That is a compound annual growth rate of 15.70%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jul 10, 2026 | 343.99B | 32.98% |
| Dec 31, 2025 | 258.67B | -5.64% |
| Dec 31, 2024 | 274.13B | 6.68% |
| Jul 10, 2024 | 256.95B | - |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Alkem Laboratories | 677.79B |
| Glenmark Pharmaceuticals | 644.24B |
| Ipca Laboratories | 453.60B |
| Ajanta Pharma | 418.20B |
| Gland Pharma | 408.50B |
| Wockhardt | 294.22B |
| Piramal Pharma | 235.12B |
| Eris Lifesciences | 198.32B |